Health Research Updates

High-Priority Pathogens in Nepal

I. National AMR Snapshot (2024–2028) Strategic Context: Under the National Action Plan, Nepal is moving toward genomic surveillance (SPEED project) and real-time digital reporting (SORMAS/EWARS). Clinical Priority (ESKAPE Group): * Acinetobacter spp.: 72% MDR (High ICU risk)K. pneumoniae: 56% MDR (Carbapenem-resistance rising). E. coli: 51% MDR (45.6% presumptive ESBL-producers).